Effect of PSD-95/SAP90 and/or PSD-93/chapsyn-110 deficiency on the minimum alveolar anesthetic concentration of halothane in mice

Anesthesiology

Volumn 112, Issue 6, 2010, Pages 1444-1451

  Tao, Feng ^a   Skinner, John ^a   Yang, Ya ^a   Johns, Roger A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; HALOTHANE; MEMBRANE PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 93; POSTSYNAPTIC DENSITY PROTEIN 95; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENERAL ANESTHESIA; KNOCKOUT MOUSE; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MOUSE; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

EID: 77953025429     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181dcd3dc     Document Type: Article

References (42)

1. Ren K, Hylden JL, Williams GM, Ruda MA, Dubner R: The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain 1992; 50:331-344
2. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ: Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res 1992; 598:271-278
3. Garry MG, Malik S, Yu J, Davis MA, Yang J: Knock down of spinal NMDA receptors reduces NMDA and formalin evoked behaviors in rat. Neuroreport 2000; 11:49-55
4. Wei F, Wang GD, Kerchner GA, Kim SJ, Xu HM, Chen ZF, Zhuo M: Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci 2001; 4:164-169
5. Lukatch HS, Kiddoo CE, Maciver MB: Anesthetic-induced burst suppression EEG activity requires glutamate-medi-ated excitatory synaptic transmission. Cereb Cortex 2005; 15:1322-1331
6. Nagele P, Metz LB, Crowder CM: Nitrous oxide (N(2)O) requires the N-methyl-D-aspartate receptor for its action in Caenorhabditis elegans. Proc Natl Acad Sci U S A 2004; 101:8791-8796
7. Pittson S, Himmel AM, MacIver MB: Multiple synaptic and membrane sites of anesthetic action in the CA1 region of rat hippocampal slices. BMC Neurosci 2004; 5:52
8. Ranft A, Kurz J, Deuringer M, Haseneder R, Dodt HU, Zieglgansberger W, Kochs E, Eder M, Hapfelmeier G: Isoflurane modulates glutamatergic and GABAergic neuro-transmission in the amygdala. Eur J Neurosci 2004; 20: 1276-1280
9. Irifune M, Takarada T, Shimizu Y, Endo C, Katayama S, Dohi T, Kawahara M: Propofol-induced anesthesia in mice is mediated by gamma-aminobutyric acid-A and excitatory amino acid receptors. Anesth Analg 2003; 97:424-429, table
10. Stover JF, Sakowitz OW, Kroppenstedt SN, Thomale UW, Kempski OS, Flugge G, Unterberg AW: Differential effects of prolonged isoflurane anesthesia on plasma, extracellular, and CSF glutamate, neuronal activity, 125I-Mk801 NMDA receptor binding, and brain edema in traumatic brain-injured rats. Acta Neurochir (Wien) 2004; 146:819-830
11. Whitehead KJ, Rose S, Jenner P: Halothane anesthesia affects NMDA-stimulated cholinergic and GABAergic modulation of striatal dopamine efflux and metabolism in the rat in vivo. Neurochem Res 2004; 29:835-842
12. Christopherson KS, Hillier BJ, Lim WA, Bredt DS: PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 1999; 274:27467-27473
13. Kornau HC, Schenker LT, Kennedy MB, Seeburg PH: Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 1995; 269:1737-1740
14. Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32:77-88
15. Tao F, Tao YX, Gonzalez JA, Fang M, Mao P, Johns RA: Knockdown of PSD-95/SAP90 delays the development of neuropathic pain in rats. Neuroreport 2001; 12:3251-3255
16. Tao F, Tao YX, Mao P, Johns RA: Role of postsynaptic density protein-95 in the maintenance of peripheral nerve injury-induced neuropathic pain in rats. Neuroscience 2003; 117:731-739
17. Zhang B, Tao F, Liaw WJ, Bredt DS, Johns RA, Tao YX: Effect of knock down of spinal cord PSD-93/chapsin-110 on persistent pain induced by complete Freund's adjuvant and peripheral nerve injury. Pain 2003; 106:187-196
18. Fang M, Tao YX, He F, Zhang M, Levine CF, Mao P, Tao F, Chou CL, Sadegh-Nasseri S, Johns RA: Synaptic PDZ domain-mediated protein interactions are disrupted by inha-lational anesthetics. J Biol Chem 2003; 278:36669-36675
19. Tao YX, Johns RA: Effect of the deficiency of spinal PSD-95/SAP90 on the minimum alveolar anesthetic concentration of isoflurane in rats. ANESTHESIOLOGY 2001; 94:1010-1015
20. Hylden JL, Wilcox GL: Intrathecal morphine in mice: A new technique. Eur J Pharmacol 1980; 67:313-316
21. Ichinose F, Huang PL, Zapol WM: Effects of targeted neu-ronal nitric oxide synthase gene disruption and nitroG-L-arginine methylester on the threshold for isoflurane anesthesia. ANESTHESIOLOGY 1995; 83:101-108
22. Engelhardt T, Lowe PR, Galley HF, Webster NR: Inhibition of neuronal nitric oxide synthase reduces isoflurane MAC and motor activity even in nNOS knockout mice. Br J Anaesth 2006; 96:361-366 (Pubitemid 43280628)
23. Liao M, Sonner JM, Jurd R, Rudolph U, Borghese CM, Harris RA, Laster MJ, Eger EI: Beta3-containing gamma-aminobutyric acidA receptors are not major targets for the amnesic and immobilizing actions of isoflurane. Anesth Analg 2005; 101:412-418, table
24. Coderre TJ, Van EI: The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests. Pain 1994; 59:345-352
25. Liu M, Liang Y, Chigurupati S, Lathia JD, Pletnikov M, Sun Z, Crow M, Ross CA, Mattson MP, Rabb H: Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol 2008; 19:1360-1370
26. Zerrate MC, Pletnikov M, Connors SL, Vargas DL, Seidler FJ, Zimmerman AW, Slotkin TA, Pardo CA: Neuroinflam-mation and behavioral abnormalities after neonatal ter-butaline treatment in rats: Implications for autism. J Pharmacol Exp Ther 2007; 322:16-22
27. Tao YX, Rumbaugh G, Wang GD, Petralia RS, Zhao C, Kauer FW, Tao F, Zhuo M, Wenthold RJ, Raja SN, Huganir RL, Bredt DS, Johns RA: Impaired NMDA receptor-mediated postsynaptic function and blunted NMDA receptor-dependent persistent pain in mice lacking postsynaptic density-93 protein. J Neurosci 2003; 23:6703-6712
28. Matsumoto M, Xie W, Inoue M, Ueda H: Evidence for the tonic inhibition of spinal pain by nicotinic cholinergic transmission through primary afferents. Mol Pain 2007; 3:41
29. Kim HW, Roh DH, Yoon SY, Seo HS, Kwon YB, Han HJ, Kim KW, Beitz AJ, Lee JH: Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice. Br J Pharmacol 2008; 154:1125-1134
30. Tao F, Skinner J, Su Q, Johns RA: New role for spinal Starga-zin in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated pain sensitization after inflammation. J Neurosci Res 2006; 84:867-873
31. Lan D, Silver DL: Fenofibrate induces a novel degradation pathway for scavenger receptor B-I independent of PDZK1. J Biol Chem 2005; 280:23390-23396
32. Tao F, Johns RA: Effect of disrupting N-methyl-D-aspartate receptor-postsynaptic density protein-95 interactions on the threshold for halothane anesthesia in mice. ANESTHESI-OLOGY 2008; 108:882-887
33. Kim E, Sheng M: PDZ domain proteins of synapses. Nat Rev Neurosci 2004; 5:771-781
34. Beique JC, Andrade R: PSD-95 regulates synaptic transmission and plasticity in rat cerebral cortex. J Physiol 2003; 546:859-867
35. Migaud M, Charlesworth P, Dempster M, Webster LC, Watabe AM, Makhinson M, He Y, Ramsay MF, Morris RG, Morrison JH, O'Dell TJ, Grant SG: Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 1998; 396:433-439
36. Stein V, House DR, Bredt DS, Nicoll RA: Postsynaptic density-95 mimics and occludes hippocampal long-term potentiation and enhances long-term depression. J Neuro-sci 2003; 23:5503-5506
37. Carlisle HJ, Fink AE, Grant SG, O'Dell TJ: Opposing effects of PSD-93 and PSD-95 on long-term potentiation and spike timing-dependent plasticity. J Physiol 2008; 586:5885-5900
38. Nicoll RA, Tomita S, Bredt DS: Auxiliary subunits assist AMPA-type glutamate receptors. Science 2006; 311:1253-1256
39. Gao S, Cheng C, Zhao J, Chen M, Li X, Shi S, Niu S, Qin J, Lu M, Shen A: Developmental regulation of PSD-95 and nNOS expression in lumbar spinal cord of rats. Neuro-chem Int 2008; 52:495-501
40. Kim J, Yao A, Atherley R, Carstens E, Jinks SL, Antognini JF: Neurons in the ventral spinal cord are more depressed by isoflurane, halothane, and propofol than are neurons in the dorsal spinal cord. Anesth Analg 2007; 105:1020-1026, table
41. Tao YX, Huang YZ, Mei L, Johns RA: Expression of PSD-95/SAP90 is critical for N-methyl-D-aspartate receptor-mediated thermal hyperalgesia in the spinal cord. Neuro-science 2000; 98:201-206
42. Boyce S, Wyatt A, Webb JK, O'Donnell R, Mason G, Rigby M, Sirinathsinghji D, Hill RG, Rupniak NM: Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: Correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 1999; 38:611-623